Neuromodulation is a rapidly growing field involving the use of bioelectric medical devices to treat neurological disorders and health issues rooted in neuro-hormonal dysfunction. While many involve the implantation of devices into the body or the brain through surgical procedures, recent advances have introduced non-invasive technologies that deliver microcurrent electronic stimulation through the skin.
Join Innerstill Co-Founders, Ellyn Ito, CEO and Laate Olukotun, Chief of Product, as they share how neuromodulation technologies have the potential to biohack the most challenging of neurological diseases as well as up-level function in elite athletes, business owners/executives, performance artists, and employees. In this webinar you will:
• Learn how neuromodulation therapies can revolutionize healthcare by providing medication-free modalities for a variety of conditions, including anxiety/depression, PTSD, addiction, dementia, long covid, sexual dysfunction, endometriosis, post partum depression, and more.
• Understand how to assess the consumer wellness technology landscape and what to look for in neuromodulation products to up-level performance or reduce stress.
• Learn how investing in novel neuromodulation technologies can diversify one’s portfolio for potential strong returns and complement other holdings in real estate, semiconductor and technology companies.
• Understand why Innerstill’s products, developed over the span of 40 years by the neuromodulation industry’s most experienced MD, PhD inventor along with a visionary integrative health practitioner have built the most safe, effective, and commercializable technologies for anyone along the continuum from floundering to flourishing.
We hope you can join us to learn more about the neuromodulation industry to identify growth opportunities, diversify your IRA holdings, support healthcare innovation, and discover new, medication-free solutions for yourself and/or a loved one.